Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.01)
# 2,754
Out of 4,814 analysts
209
Total ratings
22.17%
Success rate
-2.07%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.00 | +800.00% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.84 | +849.22% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.55 | +317.58% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.77 | +44.40% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.44 | +38.89% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.86 | +830.23% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.91 | +894.76% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.24 | +837.50% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.66 | +803.61% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.35 | +1,892.03% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.17 | +754.70% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.61 | +228.52% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.88 | +467.67% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.00 | +216.67% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $1.16 | +30,072.41% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.99 | +436.01% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.22 | +391.80% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.95 | +10,426.32% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.20 | +1,400.00% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.01 | +1,880.00% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.67 | +429,055.31% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.37 | +6,656.76% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $19.70 | +1,118.27% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.85 | +9,367.46% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.95 | +10,442.96% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.20 | +153,746.15% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.27 | +453.36% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.56 | +1,071.88% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.01 | +1,895.01% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.25 | +7,051.37% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.38 | +262.32% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $2.12 | +67,824.53% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $39.48 | -39.21% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.34 | +255,123.88% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.14 | +889,829.74% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.00
Upside: +800.00%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.84
Upside: +849.22%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.55
Upside: +317.58%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.77
Upside: +44.40%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.44
Upside: +38.89%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.86
Upside: +830.23%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.91
Upside: +894.76%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.24
Upside: +837.50%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.66
Upside: +803.61%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $7
Current: $0.35
Upside: +1,892.03%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.61
Upside: +228.52%
Mar 4, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +467.67%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.00
Upside: +216.67%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $1.16
Upside: +30,072.41%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.99
Upside: +436.01%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.22
Upside: +391.80%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.95
Upside: +10,426.32%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.20
Upside: +1,400.00%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.01
Upside: +1,880.00%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.67
Upside: +429,055.31%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.37
Upside: +6,656.76%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $19.70
Upside: +1,118.27%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.85
Upside: +9,367.46%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.95
Upside: +10,442.96%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.20
Upside: +153,746.15%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.27
Upside: +453.36%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.56
Upside: +1,071.88%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.01
Upside: +1,895.01%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.25
Upside: +7,051.37%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $2.12
Upside: +67,824.53%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $39.48
Upside: -39.21%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.34
Upside: +255,123.88%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.14
Upside: +889,829.74%